E

ECCOGENE

11 employees

Eccogene discovers and develops translational medicine in metabolic and immune-related diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

small molecule
Health Care
immune
metabolism

Date founded

2018

Funding rounds raised

Total raised

$25M

from 7 investors over 7 rounds

E

ECCOGENE raised $25M on June 12, 2023

Investors: Delos Capital, Acusea/Huiyuan Capital, New Alliance Capital and 青松基金

E

ECCOGENE raised $15M on September 6, 2018

Investors: 泰福资本 TF Capital, Med-Fine Capital and Sinopharm Capital 国药资本

FAQ